Global University Venturing

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

QuantumCTek has filed for a $102m initial public offering, more than a decade after being spun out of University of Science and Technology of China.

Existing backer Legend Capital contributed to an eight-figure dollar round for the Tsinghua-backed chemistry services provider.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The UC Berkeley-linked cell biology technology provider has raised about $215m in venture funding.

UCLA has been named as the first university partner of an academic collaboration bridge backed by Evotec, Samsara BioCapital and KCK.

Wuxi AppTec and Pfizer have both contributed as the Yale University-founded cancer drug developer prepares for clinical testing next year.

Syncona supplied a third of the investment and retains a majority stake in Freeline, which is based on research at UCL.

Chinese Academy of Sciences-backed laser-diode chip foundry Everbright Photonics has now raised $63.3m since it was founded in 2012.